Navigation Links
Rigel to Present at Two Upcoming Investor Conferences
Date:8/25/2011

SOUTH SAN FRANCISCO, Calif., Aug. 25, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, chairman and chief executive officer, and Ryan Maynard, executive vice president and chief financial officer of Rigel, will present at two separate investor conferences in September. Details of the events are as follows:Stifel Nicolaus Healthcare Conference 2011Date: Thursday, September 8th at 10:20 a.m. ETLocation: Boston, MASpeaker: James M GowerUBS Global Life Sciences ConferenceDate: Tuesday, September 20th at 1:30 p.m. ETLocation: New York, NYSpeaker: Ryan MaynardBoth presentations will be webcast.  To access the live audio webcast or subsequent archived recording, log on to www.rigel.com.  Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com)Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral syk inhibitor that has started its Phase 3 clinical trial program for rheumatoid arthritis, and R343, an inhaled syk inhibitor that has completed Phase 1 trials for asthma.

Contact: Ryan Maynard
Phone: 650.624.1284
Email: invrel@rigel.com


'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Rigel to Present at Wells Fargo Securities Healthcare Conference
2. Rigel to Present at Jefferies Global Healthcare Conference
3. Rigel Announces Pricing of Public Offering of Common Stock
4. Rigel Announces Proposed Public Offering of Common Stock
5. Rigel to Present at Bank of America Merrill Lynch Health Care Conference
6. Rigel Announces First Quarter Financial Results
7. Rigel Announces Fourth Quarter and Year End 2010 Financial Results
8. Rigel to Present at Three Upcoming Investor Conferences
9. Rigel Announces Participation at Two Investor Conferences
10. Rigel to Present at JP Morgan Healthcare Conference
11. Rigel Announces Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... IRVINE, Calif. , July 30, 2015 /PRNewswire/ ... Novartis /Alcon executives have recently contacted the Company ... will begin as early as Monday, August 3, ... been quoted as saying that the coming electronic ... billions of dollars over the next several years.  ...
(Date:7/30/2015)... N.J., July 30, 2015 PTC Therapeutics, Inc. ... and reported financial results for the second quarter ending ... on many fronts across the organization.  We are excited ... muscular dystrophy clinical trial ever conducted with topline results ... Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. "Translarna is ...
(Date:7/30/2015)...  Growth of the U.S. nonprescription market is primarily ... users to the OTC market. Due to an increasingly ... switch activity over the next five years with several ... brands entering the market into existing categories. ... (even those with low to moderate likelihood), the market ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... WASHINGTON, May 14, 2012  The Consumer Healthcare Products ... for signing into law House Bill 2263—anti-meth legislation ... becomes the 23rd state to adopt real-time, stop-sale ... (NPLEx). The proven system—in a ...
... CAMBRIDGE, Mass. and SCHLIEREN-ZURICH, Switzerland, May 14, 2012 ... announced today that it has entered into collaboration with ... ALS (aka Motor Neuron or Lou Gehrig,s disease). ... http://photos.prnewswire.com/prnh/20110204/DC42625LOGO ) "Maintaining the health ...
Cached Medicine Technology:CHPA Applauds Arizona's Adoption Of HB 2263 2The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease 2The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease 3
(Date:8/1/2015)... ... 01, 2015 , ... “ reTXT ” was featured on NewsWatch as part ... on the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch ... clarify, edit and delete any message including ones already sent. , While text messaging ...
(Date:7/31/2015)... ... July 31, 2015 , ... That’s right, the ... the STASH awards? The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, ... as tried-and-true products that have stood the test of time. These include lighting ...
(Date:7/31/2015)... New York, New York (PRWEB) , ... July 31, 2015 , ... ... started to strut their stuff, Super-Sod debuted their new type of sod called ... with registered trademark application in process. , To commemorate introduction of this new type ...
(Date:7/31/2015)... ... 2015 , ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, ... is the Super Bowl. In the two weeks that separate the conference championships and the ... 2016 Super Bowl game will mark the 50th time it has been held and the ...
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New York’s ... It was also the first provider of Exilis non-surgical fat reduction in New York. ... it has attracted a large International clientele. Many patients travel to New York ...
Breaking Medicine News(10 mins):Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2
... of the mouth by trained health workers can help in ... oral cancer mortality rate. ,A research done by scientists ... to visually screen people for oral cancer in order to ... oral cancer patients. ,Oral cancer is the growth of ...
... gets bacterial infections from the bacteria Pseudomonas.// Treatment ... Research suggests that antibiotic treatment may encourage the ... infection. ,Cystic fibrosis is disease of genetic ... mucus that affects the lungs and can cause ...
... newer form of chicken pox vaccine to// effectively control the ... herpes zoster) is the condition that gets symptoms of rashes ... pain, tingling, and numbness on the area. There may be ... somewhat like chicken pox and is caused by the same ...
... College of Georgia had successfully made a protein// that will ... growth of blood vessels that may lead to obstructed vision ... applied to animals suffering from corneal injury or skin cancer ... two third of its growth. The protein is all set ...
... be at higher risk of cardiovascular disease from the// heightened ... are at higher levels, there had been more reports of ... the days the air contains more pollutant particles, the ability ... in diabetic people. ,Impaired vascular reactions in diabetic ...
... the body from the food being heated in a plastic// ... development of the fetus in womb enough to cause breast ... research, which is published in the current edition of the ... the damage. ,Bisphenol-A (BPA) is a chemical founding the ...
Cached Medicine News:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: